Factors Determining Clonal Selection in Germinal Centres

Every time the body fights an infection, a microscopic Darwinian contest unfolds inside the lymph nodes. This project investigates the rules of that contest—specifically, how immune cells called B cells compete to produce the most effective antibodies. Current textbooks say that B cells mutate their antibody genes, then migrate to a “light zone” where they must win help from T cells to survive and multiply. But the researchers have found evidence that this textbook picture is incomplete. Their unpublished data show that T cell help is not required for B cells to re-enter the cell cycle, contradicting a core assumption. They also suspect a second checkpoint exists even earlier, where B cells need a signal from their own antibody receptor just to enter the light zone. If successful, this work will rewrite the fundamental understanding of how the body selects its best antibodies. That matters because many vaccines and antibody-based therapies depend on this selection process working correctly. Deeper knowledge could eventually help design vaccines that produce stronger, longer-lasting immunity, or improve treatments for autoimmune diseases where selection goes wrong. This is fundamental science—it does not promise an immediate product, but past discoveries about germinal centres have directly shaped how we make flu vaccines and cancer immunotherapies.